ParagonRx Names William L. Holden To Lead Pharmaceutical Safety Strategies
7/7/2010 11:03:42 AM
WILMINGTON, Del.--(BUSINESS WIRE)--ParagonRx, an inVentiv Health, Inc. company (Nasdaq: VTIV) and a leading consulting company specializing in pharmaceutical risk management and optimizing medication, has named William L. (Billy) Holden as chief safety officer. Holden has almost 20 years experience working at top levels for major drug companies in the areas of pharmacoepidemiology, signal detection and risk management.
comments powered by